Full Text View
Tabular View
No Study Results Posted
Related Studies
Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer
This study is ongoing, but not recruiting participants.
Study NCT00022373   Information provided by National Cancer Institute (NCI)
First Received: August 10, 2001   Last Updated: May 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Head and Neck Cancer
Radiation Toxicity
Additional conditions recognized in this trial
Head and Neck Neoplasms
Mucositis
Stomatitis
More general conditions related to this trial
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Mouth Diseases
Neoplasms
Neoplasms by Site
Stomatognathic Diseases
Interventions listed in this trial
iseganan HCl oral solution
management of therapy complications
Sponsors listed in this trial
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services